FOXO3 and neoplasm: Consistent with these reports, downregulation of FOXO3a could significantly augment IKKβ-mediated tumor growth in nude mice and lead to apoptosis resistance in conjunction with elevated glycolysis that is the important for tumor growth and survival, suggesting that FOXO3a is a determinant of tumor progression and chemotherapeutic response [14], [38].